Newron Pharmaceuticals S.p.A.
$20.00▲ 0.00%(+$0.00)
TickerSpark Score
42/100
▌ Weak
53
Valuation
60
Profitability
10
Growth
28
Health
60
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NWPHF research report →
52-Week Range100% of range
Low
$9.36
Current
$20.00
High
$20.00
Company Overviewwww.newron.com
About the company
Newron Pharmaceuticals S. p. A.
- CEO
- Stefan Weber
- IPO
- 2017
- Employees
- 22
- HQ
- Bresso, MI, IT
Price Chart
+221.54% · this period
Valuation
- Market Cap
- $416.12M
- P/E
- -19.71
- P/S
- 14.44
- P/B
- -23.83
- EV/EBITDA
- -66.66
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.94%
- Op Margin
- -24.59%
- Net Margin
- -69.29%
- ROE
- 277.88%
- ROIC
- -17.05%
Growth & Income
- Revenue
- $19.13M · -62.78%
- Net Income
- $-13,239,000 · -183.56%
- EPS
- $-0.66 · -177.65%
- Op Income
- $-4,697,000
- FCF YoY
- 283.25%
Performance & Tape
- 52W High
- $20.00
- 52W Low
- $9.36
- 50D MA
- $20.00
- 200D MA
- $12.87
- Beta
- 0.74
- Avg Volume
- 786.333
Get TickerSpark's AI analysis on NWPHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · NWPHF
Our NWPHF coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on NWPHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NWPHF report →Internal Compare
Similar companies
Peers in the same neighborhood.